Achieving agility to foster innovation and bring value to patients
21 October 2021 | Annual Conference
09:00
Conference opening and welcome address
Shayesteh Fürst-Ladani, SFL, President MPP Association
Welcome address
Invited
MPP2021 Program Committee Chair Introduction
Dorit Prüfer, Roche
09:30
Keynote address
Invited
10:00
Break & 1-on-1 partnering
10:30
Panel discussion: Chair: Shayesteh Fürst-Ladani, SFL, President MPP Association
Salvatore Scalzo, European Commission
Khair ElZarrad, US Food & Drug Administration
Wiebke Löbker, German Federal Institute for Drugs and Medical Devices
Jonathan Sutch, Team-NB
Birka Lehmann, University of Bonn
12:00
Break & 1-on-1 partnering
13:15
Parallel sessions
Session 1: Achieving a supporting regulatory framework
Chair: Beatrice Oberle-Rolle, SFL
Paul Scannell, Medicines for Europe
Christiana Hofmann, TÜV SÜD
Ilona Reischl, AGES
MHRA (confirmed, speaker TBD)
Session 2: How digital healthcare creates value
Chair: Ruth Foster, MSD
Rado Andrian, Capgemini Engineering
Industry (invited)
Liesbet Geris, University of Liège
14:45
Break & 1-on-1 partnering
15:15
Parallel sessions
Session 3: Patient engagement in product development
Chairs: Karin Herzog, Boehringer Ingelheim & Marie Picci, Novartis
Dominique Hamerlijnck, atini
Rémy Kohler, Roche
Raimund Erdmann, Erdmann Design
David Pas, Verhaert
Session 4: Innovative approaches for combined products
Chairs: David Haerry, European AIDS Treatment Group Brussels
& Daniel Delfosse, Swiss Medtech
Hicham Majd, Novartis
Sebastian Gerner, Ypsomed
Beat Walther, Vendbridge AG
Marisa Papaluca, Visiting Professor, Imperial
College London, Expert WHO, Former EMA
Senior Scientific Advisor
16:45
Closing remarks
Shayesteh Fürst-Ladani, SFL, President MPP Association
Dorit Prüfer, Roche
MPP 2021 Sponsors
MPP 2021 event partner
MPP 2021 media partner
MPP 2021 networking partner
